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mtDNA mutationwas studied in lymphocytes from patients with neuropathy, ataxia, and retinitis
pigmentosa (NARP), caused by a mutation at leu-156 in the ATPase 6 subunit. The mutation giving the milder
phenotype (Leu156Pro) suffered a 30% reduction in proton ﬂux, and a similar loss in ATP synthetic activity.
The more severe mutation (Leu156Arg) also suffered a 30% reduction in proton ﬂux, but ATP synthesis was
virtually abolished. Oligomycin sensitivity of the proton translocation through F0 was enhanced by both
mutations. We conclude that in the Leu156Pro mutation, rotation of the c-ring is slowed but coupling of ATP
synthesis to proton ﬂux is maintained, whereas in the Leu156Arg mutation, proton ﬂux appears to be
uncoupled. Modelling indicated that, in the Leu156Arg mutation, transmembrane helix III of ATPase 6 is
unable to span the membrane, terminating in an intramembrane helix II–helix III loop. We propose that the
integrity of transmembrane helix III is essential for the mechanical function of ATPase 6 as a stator element in
the ATP synthase, but that it is not relevant for oligomycin inhibition.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
The F1F0-ATPase (ATP synthase) of mitochondria synthesizes ATP
from ADP and Pi using a proton-motive force as energy source. It is
composed of two domains: the catalytic moiety F1, which is connected
to the transmembrane portion, F0 via a stalk. The proton-motive force
powers ATP synthesis by driving rotation of the stalk and F0-c-ring
within a stator comprising the catalytic subunits of F1 plus some other
components of F0.
The F1 structure is well deﬁned, whereas the structure of F0, the
membrane sector, is still unknown. However, the functions of various
F0 components are known (for recent review see [1]). ATPase 6, the
mitochondrial homologue of the bacterial subunit F0-a, is a component
of the F0 stator, and plays an essential role in translocating protons, and
in coupling this process with chemical catalysis occurring on F1 [2–4].
The three-dimensional structure of ATPase 6, comprising 223 amino
acids, is unknown, but molecular modelling [5,6] and analogy with
Escherichia coli subunit a, predict that it contains a functional bundle
of 4 membrane-spanningα helices named I through IV. Helix III in theembrane helices for energy
a “G. Moruzzi”, Università di
9 051 2091215; fax: +39 051
i).
l rights reserved.human enzyme is homologous to bacterial helix IV, and contains two
essential residues, arg-159 and leu-156. On the basis of the bacterial
homologue, arg-159 is thought to form an ion pair with glu-58 of the
subunit c, and thus participate in proton ﬂow [7]. Cox et al. [2]
speculated that the bulky hydrophobic leu-156 residue of ATPase 6
might position glu-58 of subunit c optimally for the proton transloca-
tion process, which may operate by protonation/deprotonation of glu-
58 inducing conformational changes of subunit c, which drive the
rotation mechanically [3,8]. An alternative model of the mechanical
cycle in F-type ATPases has recently been proposed by Dimroth et al.
[9,10], based on the structure of the rotor ring of the Na+-ATPase from
Ilyobacter tartaricus. The main structural feature of this model is the
presence of the ion binding glu-65 of c subunits facing towards the
outer surface of the rotor ring, which suggests that a conformational
change may not be necessary for generating torque for rotation of the
F0 c-ring [3,8,11].
Therefore, many questions still remain regarding the coupling
between proton transport and rotational motion.
To acquire a clearer understanding of the role of leu-156 in ATPase 6
of mitochondria, we analyzed the properties of two naturally-occurring
mutations, Leu156Arg and Leu156Pro, in human cells. These are asso-
ciated with mitochondrial dysfunction, and cause severe syndromes of
energy deﬁciency [12,13], although we have shown elsewhere that the
primarymechanism of pathological damage is different in the two cases
[14]. The results shown here on the human enzyme, and elsewhere
using directedmutagenesis of the homologous bacterial enzyme [15,16],
indicate that the two mutations act differently on proton translocation,
Fig. 1. RH-123 ﬂuorescence changes in digitonin-permeabilized wild-type and mutant lymphocytes by energization with succinate. (a) Kinetics of the positively charged RH-123
accumulation as monitored by measuring time-dependent ﬂuorescence quenching of the probe entering the mitochondrial matrix [14,17]of permeabilized lymphocytes. The sample
mixture contained an ADP regenerating system (5 U/ml hexokinase and 10 mM glucose), 50 nM rhodamine-123, 0.5 mM ADP, 4 µM rotenone, 33 nM cyclosporine A and 15 µg/ml
digitonin. RH-123 ﬂuorescence decay kinetics (λex=503 nm; λem=527 nm) were induced by the addition of 20 mM succinate to the sample pre-incubated with (state 4 respiratory
condition) or without (state 3 respiratory condition) 0.2 µM oligomycin. (b) The RH-123 ﬂuorescence quenching initial rate ((ΔF/Fi)/s/106 cells) as calculated from the above diagrams
is reported as percent, being 100% the mean value of the controls measured in the presence of saturating oligomycin (1.642 ΔF/Fi/s/106 cells) and 0% the mean value obtained under
maximal ADP phosphorylation rate (0.204 ΔF/Fi/s/106 cells). Mean+/−SD of two to four assays are reported for each lymphocyte preparation. Asterisks indicate statistically signiﬁcant
differences (Pb0.01) between patient and control lymphocytes or between oligomycin-treated and untreated lymphocytes.
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modelling approaches, we arrive at a structural model of ATPase 6
which indicates the importance of this residue in maintaining a full
length α-helix III, and hence accounts for the different dysfunctions of
the F1F0-ATPase caused by changing leu-156 of the ATPase 6 subunit.
2. Materials and methods
Lymphocytes were obtained from patients (8993TNG, n=5; 8993TNC, n=2) and
healthy age-matched individuals (n=12), following the protocol described in [6]. The
levels of mutation were established by standard protocols, as previously reported [14].
The level of mutation was 79–94% and 90–94% for the T→G and T→C patients'
lymphocytes, respectively.Fig. 2. Oligomycin sensitivity of proton transport through F0 in human mtDNA 8993TNG
permeabilized cells were incubated with oligomycin at various concentrations, as indicated
transport activity is shown relative to 100% inhibition at 0.2 μM oligomycin. The inset reports
red line: 8993TNC mutant cells.Proton ﬂux through F0 was analyzed using the ﬂuorescence of rhodamine-123 as a
probe, according to the method recently reported [17]. Brieﬂy, lymphocytes (4×106/ml)
were suspended in a respiratory buffer (250 mM sucrose, 10 mMHEPES, 0.1 mM K-EGTA,
2 mM MgCl2, 4 mM KH2PO4, pH 7.4) containing an ADP regenerating system (5 U/ml
hexokinase and 10 mM glucose) and 50 nM rhodamine-123, incubated with 33 nM
cyclosporine A, 4 µM rotenone, 0.5 mM ADP and then permeabilized by adding 15 µg/ml
digitonin. Pre-incubationwas in the presence of oligomycin (0.2 µM) (‘state 4 respiration')
or in its absence (‘state 3 respiration’) as indicated. RH-123 ﬂuorescence quenching
(λex=503 nm;λem=527 nm)was induced by the addition of 20mM succinate. (ΔF/Fi/s/106
cells) is anexpressionof thedecay rate of RH-123ﬂuorescence, and isdirectly related to the
F0 proton translocation rate [18].
Protein concentration of samples was assessed by the method of Lowry et al. [19] in
the presence of 0.3% (w/v) sodium deoxycholate. Bovine serum albumin was used as
standard.and TNC mutant cells. Rhodamine quenching was measured as in Fig. 1, except that
, for 3 min at room temperature prior to addition of succinate. Inhibition of the proton
the abscissa 4-fold expanded. Black line: control cells; blue line: 8993TNGmutant cells;
943G. Solaini et al. / Biochimica et Biophysica Acta 1777 (2008) 941–945Modelling of the structure of the ATPase-6 subunit is based on the 3D model of the
E. coli ac12 complex [3] (Protein Data Bank entry 1C17): transmembrane α-helices are
predicted by homology modelling software (ESyPred3D, Lambert C. 2002) [20].
3. Results and discussion
Bacterial subunit a (and its mitochondrial homologue, ATPase 6)
plays a major role in proton translocation through F0, and as a stator
involved in the rotation of the c-ring. Leu-156 (human numbering) is a
conserved residue of the ATPase 6 subunit, and its mutation gives rise
to an energy-deﬁcient phenotype ‘neuropathy, ataxia, and retinitisFig. 3. Ribbon models of the predicted transmembrane α-helices of wild-type and mutan
membrane domain were created based on the coordinates of the E. coli subunit a (1C17), and
modelling software was ESyPred3D (20) (http://www.fundp.ac.be/sciences/biologie/urbm/bi
to the E. colimodel, consists of fourα-helices. The essential arg-159 and leu-156 are shownw
is either red (Arg) or ochre (Pro). The green arrow indicates the position where helix III is inte
in two orientations at right angles to each other. (b) View in the plane of the membrane fropigmentosa’ (NARP) in humans, showing that this residue is important
for subunit function [21,22]. Leu-156 cannot itself carry protons.
However, it occupies a critical position three amino acids away from
(and hence, on a helix turn, directly above) the functionally essential
arg-159, suggesting that it could inﬂuence proton translocation [2], or
torque generation [3,8], via the a–c interaction. It has been shown that
human ATP synthase carrying a Leu156Arg mutation is severely
defective in ATP synthesis, but unlike the bacterial homologue [15], it
is still fully assembled [23,24], and it is sensitive to saturating
oligomycin [14,22,24]. A second mutation in this position, Leu156Pro,t human ATPase 6 subunits of ATP synthase. The homology models of the ATPase 6
human ATPase 6 subunit (amino acid sequence 62–223) in the Protein Data Bank. The
oinfo/esypred/). The ATPase 6 membrane domain spans the lipid bilayer and, according
ith space-ﬁlling spheres in red and yellow, respectively, whereas the mutant amino acid
rrupted in Leu156Arg mutant cells. (a and a′) View perpendicular to the cell membrane,
m the mitochondrial matrix.
Fig. 3 (continued ).
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correspondingly has been associated with a much lower impairment
of ATP synthesis than the Leu156Arg mutation [14,25].
Proton translocation through F0 in thesemutants was estimated by
following rhodamine ﬂuorescence quenching in digitonin-permeabi-
lized cells. Typical traces are shown inFig. 1a. In permeabilized
lymphocytes, oligomycin inhibits the use of the proton gradient by the
F1F0 complex, resulting in a higher membrane potential (and hence a
higher rate of quenching) than in mitochondria using the proton
gradient to phosphorylate ADP (state 3 respiration) (compare upper-
most and lowest traces). The central traces indicate that the F0 proton
translocation (state 3 respiration) in both mutants is similar and lower
than the control, as shown quantitatively in Fig. 1b.
Recent studies have shown that ATP synthesis in cells carrying the
Leu156Pro mutation (at levels close to homoplasmy) is slowed by less
than 25% [14,26], correlating closely with the 30% decrease in proton
translocation rate. However, in the Leu156Arg mutation, the ATP
synthesis rate declines much more severely, to only 5% of normal.
[14,26]. While this biochemical observation explains the relative
severity of the patient symptoms, it also indicates that the loss in ATP
synthesis in Leu156Arg cannot simply be due to the decrease in proton
translocation rate. ATP synthesis must also be lost by this mutation
disrupting the coupling of ATP synthesis to proton translocation across
the membrane. Thus Leu156Arg decreases the ability of the ATP
synthase to extract energy from proton translocation, as recently
discussed [6]. Since coupling involves the rotation of the c-ring/stalk
relative to the head group/stator, it could be that, in this mutant, H+
can be translocated (though at a lower rate than in wild-type F0)
without driving rotation of the c-ring (‘leak' pathway) or, alternatively,
that the rotation occurs but the link to F1 (and hence ATP synthesis) is
disrupted. Therefore, the twomutations impair ATP synthesis through
two different mechanisms. In the Leu156Pro mutant enzyme, there
are parallel decreases of both ATP synthesis and proton translocation
rates, which can be explained if the rotation rate of the c-ring simply
decreases due to a decreased rate of proton translocation. In contrast,
the Leu156Arg mutation decreases ATP synthesis much more severely
than it decreases proton translocation rate suggesting, in addition, a
defect in coupling.
The inhibitor oligomycin speciﬁcally affects proton translocation
through F0, and was used to probe these mutants. Fig. 2 shows the
effect of oligomycin on the proton ﬂux through the mutant enzymes.
Oligomycin inhibits proton ﬂux in both mutants essentially to the
levels seen in wild-type, indicating that the overall assembly of the
proton channel is normal in all three cases. However, both the
Leu156Arg and the Leu156Pro mutations had an increased oligomycin
sensitivity (I50 1.6 and 2.1 nM, respectively), which was one order ofmagnitude higher than that shown by controls (I50=24 nM). It
appears, therefore, that in either case, removal of leu-156 from ATPase
6 promotes the association of F1F0 with oligomycin, either by making
its access easier (by removing a hydrophobic and bulky side chain) or
by destabilising the native conformation of F0 relative to its
oligomycin-inhibited conformation. Early work suggested subunits 6
and 9 as sites of oligomycin binding to yeast ATP synthase [27–29], and
it has been suggested that the binding site of this inhibitor may extend
from the surface of the membrane in the mitochondrial ATPase 6
region (equivalent to the loop region of a-Glu196 in E. coli) to the area
around c-Glu58 in the midst of the bilayer [30]. Our observations
support this view, indicating that changing the conserved residue
a156-leu in human ATP synthasemodulates the oligomycin sensitivity
of the enzyme. The participation of several polypeptides in oligomycin
sensitivity is also supported by the work of Devenish et al. [31] on the
yeast F1F0-ATPase, who report a twofold increase in oligomycin
sensitivity when the C-terminal 40 residues of rat OSCP replaced the
equivalent yeast residues. Since it is rather unusual that mutations in
two different subunits of ATP synthase can both induce a stronger
binding of an inhibitor than to the wild-type enzyme, our results
support the idea of an “oligomycin axis” of mitochondrial ATP
synthase, which includes OSCP and the proton channel [31].
To explore the structural basis of the differences between the
effects of the two mutations, the work presented here, taken in
combination with recent work from our laboratory and homology
with the bacterial subunit a, allows us to formulate a model for the
transmembrane domain of the ATPase 6 subunit (Fig. 3). In E. coli
ATPase-a [3,4,32], a bundle of ﬁve α-helices was predicted with
helices II–V taking part in the proton translocation and energy
transduction by the ATP synthase. These four α-helices were
homologous to transmembrane helices I–IV predicted for human
ATPase 6. In the mutants, modelling suggests that proline can be
accommodated at position 156 while still maintaining transmem-
brane helix III. In contrast, substitution of leu-156 by arginine has
signiﬁcant consequences for transmembrane helix stability, and is
predicted to havemajor effects on the structure of helix III. This helix is
now unable to span the membrane, with the helical turn proximal to
the matrix aqueous phase being lost and replaced by an unstructured
region (Fig. 3).
We propose that a full length helix III is important for coupling. In
the Leu156Pro mutant, while a poor ‘ﬁt’ to the c-ring might slow
down rotation, the matrix-end of this helix is still able to act as a
fulcrum for forces exerted by during each protonation/deprotonation
cycle of a subunit c [3]. However, in the Leu156Arg mutation, the
helix is disrupted, and this region is too ﬂexible to transmit force;
protons may pass through a pathway at least in part different from
945G. Solaini et al. / Biochimica et Biophysica Acta 1777 (2008) 941–945the physiological one [6], but the stator function of ATPase 6 is lost
and no rotation is generated. Since pathological mutations in ATPase
6 (and phenotypic mutations in E. coli ATPase-a) are largely restricted
to helix III of this subunit [2,33,34], this is clearly a critical region for
ATP synthase function, and, in summary, we would propose that leu-
156 (or the region of the helix around it) has an important mechanical
function in the stator role of ATPase 6. Leu156Pro slows down proton
ﬂow through F0 – probably through a steric effect on rotation rate –
but the mechanical element, helix III, is maintained and the coupling
of proton movement to rotation of the c-ring is still possible.
Alternatively, if rotation of the c-ring is essentially based on
Brownian motions between the ion release and uptake channels, as
proposed by Dimroth et al. [10], the a Leu156Arg change, by
introducing a second positive charge in proximity of arg-159, might
prevent rotation of the c-ring. However, even in this case, the
uncoupled and relatively slow proton ﬂow through F0 must result
from the partial loss of the helix III structure allowing a direct proton
ﬂow (possibly involving both the c glu-58 carboxylate and the a arg-
156 guanidinium) from the ion access half-channel to the release half-
channel of ATPase 6 subunit [35,36], thus short-circuiting the pathway.
Thus the study of these mutants, apart from their pathological
importance, also gives insight as to how proton-motive force
generates rotation of the c-ring and oligomycin interacts with the
F1F0-ATPase, both being questions still unresolved. As a corollary, it is
interesting that oligomycin binds themutant enzymes with an afﬁnity
10-fold higher than that for the normal enzyme, therefore supporting
the suggestion [37] that this inhibitor might form the basis for
pharmacological approaches to reduce the proportion of mutant vs
normal ATP synthase in tissues of patients.
Acknowledgments
This work was supported by Comitato Telethon Fondazione Onlus,
Roma, project number GP0280/01 to G. Solaini. Sgarbi, G. was supported
by the PRIN-06 grant “Apoptosis and mitochondria: new targets in
neoplastic, degenerative and immunologic diseases”. We thank Drs. V.
Carelli and L. Valentino for supplying the blood sample of patients.
References
[1] J.E. Walker, V.K. Dickson, The peripheral stalk of the mitochondrial ATP synthase,
Biochim. Biophys. Acta 1757 (2006) 286–296.
[2] S.M. Howitt, A.J. Rodgers, L.P. Hatch, F. Gibson, G.B. Cox, The coupling of the relative
movement of the a and c subunits of the Fo to the conformational changes in the
F1-ATPase, J. Bioenerg. Biomembranes. 28 (1996) 415–420.
[3] V.K. Rastogi, M.E. Girvin, Structural changes linked to proton translocation by
subunit c of the ATP synthase, Nature 402 (1999) 263–268.
[4] S.B. Vik, J.C. Long, T. Wada, D. Zhang, A model for the structure of subunit a of the
Escherichia coli ATP synthase and its role in proton translocation. Biochim. Biophys.
Acta 1458 (2000) 457–466.
[5] S.M. Howitt, L.N. Lightowlers, F. Gibson, G.B. Cox, Mutational analysis of the
function of the a-subunit of the F1F0-ATPase of Escherichia coli, Biochim. Biophys.
Acta 1015 (1990) 264–268.
[6] G. Sgarbi, A. Baracca, G. Lenaz, L.M. Valentino, V. Carelli, G. Solaini, Inefﬁcient
coupling between proton transport and ATP synthesis may be the pathogenic
mechanism for NARP and Leigh syndrome resulting from the T8993G mutation in
mtDNA, Biochem. J. 395 (2006) 493–500.
[7] R.H. Fillingame, C.M. Angevine, O.Y. Dmitriev, Mechanics of coupling proton
movements to c-ring rotation in ATP synthase, FEBS Lett. 555 (2003) 29–34.
[8] A. Aksimentiev, I.A. Balabin, R.H. Fillingame, K. Schulten, Insights into themolecular
mechanism of rotation in the Fo sector of ATP synthase, Biophys. J. 86 (2004)
1332–1344.
[9] T. Meier, P. Polzer, W.W. Diederichs, P. Dimroth, Structure of the rotor ring of F-type
Na+-ATPase from Ilyobacter tartaricus, Science 308 (2005) 659–662.
[10] P. Dimroth, C. von Ballamoos, T. Meier, Catalytic and mechanical cycles in F-ATP
synthases, EMBO Rep. 7 (2006) 276–282.[11] O.D. Vincent, B.E. Schwem, P.R. Steed, W. Jiang, R.H. Fillingame, Fluidity of structure
and swivelling of helices in the subunit c ring of Escherichia coli ATP synthase as
revealed by cysteine–cysteine cross-linking. J. Biol. Chem. 282 (2007) 33788–33794.
[12] R.W. Taylor, D.M. Turnbull, Mitochondrial DNA mutations in human disease,
Nature Rev. Genet. 6 (2005) 389–402.
[13] G. Lenaz, A. Baracca, V. Carelli, M. D'Aurelio, G. Sgarbi, G. Solaini, Bioenergetics of
mitochondrial diseases associated withmtDNAmutations, Biochim. Biophys. Acta-
Bioenergetics. 1658 (2004) 89–94.
[14] A. Baracca, G. Sgarbi, M. Mattiazzi, G. Casalena, E. Pagnotta, M.L. Valentino, M.
Moggio, G. Lenaz, V. Carelli, G. Solaini, Biochemical phenotypes associatedwith the
mitochondrial ATP6 gene mutations at nt8993, Biochim. Biophys. Acta Bioenerg
767 (2007) 913–919.
[15] P.E. Hartzog, B.D. Cain, The a leu207 arg mutation in F1F0-ATP synthase from
Escherichia coli. A model for human mitochondrial disease, J Biol Chem. 268 (1993)
12250–12252.
[16] I. Ogilvie, R.A. Capaldi, Mutations of the mitochondrially encoded ATPase 6 gene
modelled in the ATP synthase of Escherichia coli. FEBS Lett. 453 (1999) 179–182.
[17] G. Solaini, G. Sgarbi, G. Lenaz, A. Baracca, Evaluating mitochondrial membrane
potential in cells, Biosci. Rep. 27 (2007) 11–21.
[18] A. Baracca, G. Sgarbi, G. Solaini, G. Lenaz, Rhodamine 123 as a probe of
mitochondrial membrane potential: evaluation of proton ﬂux through Fo during
ATP synthesis, Biochim. Biophys. Acta Bioenerg. 1606 (2003) 137–146.
[19] O.H. Lowry, N.J. Rosenbrough, A.L. Farr, R.J. Randall, Protein measurement with the
Folin phenol reagent, J. Biol. Chem. 193 (1951) 265–275.
[20] C. Lambert, N. Leonard, X. De Bolle, E. Depiereux, ESyPred3D: prediction of
proteins 3D structures, Bioinformatics 18 (2002) 1250–1256.
[21] I.J. Holt, A.E. Harding, R.K. Petty, J.A. Morgan-Hughes, A newmitochondrial disease
associated with mitochondrial DNA heteroplasmy, Am. J. Hum. Genet. 46, (1990)
428–433.
[22] A. Baracca, S. Barogi, V. Carelli, G. Lenaz, G. Solaini, Catalytic activities of
mitochondrial ATP synthase in patients withmitochondrial DNA T8993Gmutation
in the ATPase 6 gene encoding subunit a, J. Biol. Chem. 275 (2000) 4177–4182.
[23] J.J. Garcia, I. Ogilvie, B.H. Robinson, R. Capaldi, Structure, functioning, and assembly
of the ATP synthase in cells from patients with the T8993G mitochondrial DNA
mutation. Comparisonwith the enzyme in Rho(0) cells completely lackingmtDNA,
J. Biol. Chem. 275 (2000) 11075–11081.
[24] P. Cortes-Hernandez, M.E. Vazquez-Memije, J.J. Garcia, ATP6 homoplasmic
mutations inhibit and destabilize the human F1F0-ATP synthase without prevent-
ing enzyme assembly and oligomerization, J. Biol. Chem. 282 (2007) 1051–1058.
[25] M.E. Vazquez-Memije, S. Schanke, F.M. Santorelli, P. Kranz-Eble, D.C. De Vivo, S.
DiMauro, Comparative biochemical studies of ATPases in cells from patients with the
T8993G or T8993C mitochondrial DNA mutations, J. Inherit. Metab. Dis. 21 (1998)
829–836.
[26] F. Pallotti, A. Baracca, E. Hernandez-Rosa, W.F. Walker, G. Solaini, G. Lenaz, G.V.
Melzi d'Eril, S. DiMauro, E.A. Schon, M. Davidson, Biochemical analysis of
respiratory function in cybrid cell lines harbouring mitochondrial DNA mutations,
Biochem. J. 384, (2004) 287–293.
[27] G.A. Breen, D.L. Miller, P.L. Holmans, G. Welch, Mitochondrial DNA of two
independent oligomycin-resistant Chinese hamster ovary cell lines contains a single
nucleotide change in the ATPase 6 gene, J. Biol. Chem. 261 (1986) 11680–11685.
[28] M.K. Ray, I.F. Connerton, D.E. Grifﬁths, DNA sequence analysis of the Olir2-76 and
Ossr1-92 alleles of the Oli-2 region of the yeast Saccharomyces cerevisiae. Analysis
of related amino-acid substitutions and protein–antibiotic interaction. Biochim.
Biophys. Acta 951 (1988) 213–219.
[29] P. Nagley, R.M. Hall, B.G. Ooi, Amino acid substitutions in mitochondrial ATPase
subunit 9 of Saccharomyces cerevisiae leading to oligomycin or venturicidin
resistance, FEBS Lett. 195 (1986) 159–163.
[30] Moore,K.J., Angevine, C.M.,Owen,D.W., SchwemB.E., Fillingame,R.H., Thecytoplasmic
loops of subunit a of Escherichia coli ATP synthase may participate in the proton
translocating mechanism J. Biol. Chem. 283 (2008) 13044–13052.
[31] R.J. Devenish, M. Prescott, G.M. Boyle, P. Nagley, The oligomycin axis of
mitochondrial ATP synthase: OSCP and the proton channel, J. Bioenerg.
Biomembranes 32, (2000) 507–514.
[32] S.B. Vik, R.R. Ishmukhametov, Structure and function of subunit a of the ATP
synthase of Escherichia coli, J. Bioenerg, Biomembranes 37, (2005) 445–449.
[33] E.A. Schon, S. Santra, F. Pallotti, M.E. Girvin, Pathogenesis of primary defects in
mitochondrial ATP synthesis, Semin. Cell Dev. Biol. 12 (2001) 441–448.
[34] B.D. Cain, R.D. Simoni, Proton translocation by the F1F0ATPase of Escherichia coli,
Mutagenic analysis of the a subunit. J. Biol. Chem. 264 (1989) 3292–3300.
[35] Steed P.R. Fillingame, R.H. Subunit a facilitates aqueous access to a membrane-
embedded region of subunit c in Escherichia coli F1F0-ATP synthase. J. Biol. Chem.
283 (2008) 12365–12372.
[36] C.M. Angevine, K.A.G. Herold, O.D. Vincent, R.H. Fillingame, Aqueous access
pathways in ATP synthase subunit a. J. Biol. Chem. 282, (2007) 9001–9007.
[37] G.Manfredi, N. Gupta, M.E. Vazquez-Memije, J.E. Sadlock, A. Spinazzola, D.C. De Vivo,
E.A. Schon, Oligomycin induces a decrease in the cellular content of a pathogenic
mutation in the human mitochondrial ATPase 6 gene, J. Biol. Chem. 274 (1999)
9386–9391.
